A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2- inducing pertussis vaccines

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1383-1390

  Mcguirk, Peter ^a   Mills, Kingston H G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; PERTUSSIS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BORDETELLA; BORDETELLA PERTUSSIS; CONTROLLED STUDY; EXPERIMENTAL INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; INFLAMMATION; LUNG INFECTION; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ANIMALS; CYTOKINES; IMMUNIZATION; INFLAMMATION; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTROPHILS; PERTUSSIS VACCINE; TH1 CELLS; TH2 CELLS;

EID: 0033970120     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1383-1390.2000     Document Type: Article

References (43)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Ad Hoc Group for the Study of Pertussis Vaccines. 1997. A randomized controlled trial of a two-component, a three-component and a five-component acellular pertussis vaccine and a British whole-cell pertussis vaccine. Lancet 350:1569-1577.
3. Ausiello, C. M., F. Urbani, A. la Sala, R. Lande, and A. Cassone. 1997. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
4. Barbic, J., M. F. Leef, D. L. Burns, and R. D. Shahin. 1997. Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect. Immun. 65:4904-4908.
5. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. G. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
6. Denis, M. 1992. Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J. Leukoc. Biol. 52:197-201.
7. Dinarello, C. A. 1987. The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol. Lett. 16:227-231.
8. Fong, T. A., and T. R. Mosmann. 1989. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J. Immunol. 143:2887-2893.
9. Greco, D., S. Salmaso, P. Mastrantonio, M. Guiliano, A. G. Tozzi, A. Anemona, M. L. Giori Delgi Atti, A. Giammanco, P. Panel, W. C. Blackwelder, D. L. Klein, S. G. F. Wassilak, and the Progetto Pertosase Working Group. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
10. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five component acellular, and a whole cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
11. Hashimoto, M., M. Shingu, I. Ezaki, M. Nobunaga, M. Minamihara, K. Kato, and H. Sumioki. 1994. Production of soluble ICAM-1 from human endothelial cells induced by IL-1 beta and TNF-alpha. Inflammation 18:163-173.
12. Held, T. K., X. Weihua, L. Yuan, D. V. Kalvakolanu, and A. S. Cross. 1999. Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect. Immun. 67:206-212.
13. Jordan, M., I. G. Otterness, R. Ng, A. Gessner, M. Rollinghoff, and H. U. Beuscher. 1995. Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist. J. Immunol. 154:4081-4090.
14. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707-710.
15. Loscher, C. E., S. Donnelly, S. McBennett, M. A. Lynch, and K. H. G. Mills. 1998. Pro-inflammatory cytokines in the adverse systemic and neurologic effects associated with parenteral injection of a whole cell pertussis vaccine. Ann. N. Y. Acad. Sci. 856:274-277.
16. Loscher, C. E., S. Donnelly, M. A. Lynch, and K. H. G. Mills. 2000. Proinflammatory cytokine induction in the brain following respiratory infection with Bordetella pertussis. J. Neuroimmunol. 102:172-181.
17. Loscher, C. E., S. Donnelly, L. O'Neill, M. A. Lynch, and K. H. G. Mills. 1999. Modulation of IL-1β levels and JNK expression in the brain following parenteral injection of a whole cell pertussis vaccine. Immunology 98(Suppl. 1):113.
18. Mahon, B. P., K. Katrak, A. Nomoto, A. Macadam, P. D. Minor, and K. H. G. Mills. 1995. Poliovirus-specific Th1 clones with cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in a transgenic mouse model. J. Exp. Med. 181:1285-1292.
19. Mahon, B. P., M. Ryan, F. Griffin, and K. H. G. Mills. 1996. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64:5295-5301.
20. Mahon, B. P., B. J. Sheahan, F. Griffin, G. Murphy, and K. H. G. Mills. 1997. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of IFN-γ receptor or immunoglobulin μ chain genes. J. Exp. Med. 186:1843-1851.
21. McGuirk, P., B. P. Mahon, F. Griffin, and K. H. G. Mills. 1998. Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur. J. Immunol. 28:153-163.
22. McGuirk, P., and K. H. G. Mills. 2000. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous haemagglutinin from Bordetella pertussis. Eur. J. Immunol. 30:415-422.
23. Mills, K. H. G., A. Barnard, J. Watkins, and K. Redhead. 1993. Cellmediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
24. Mills, K. H. G., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
25. Mulligan, M. S., M. L. Jones, A. A. Vaporciyan, M. C. Howard, and P. A. Ward. 1993. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 151:5666-5674.
26. Mulligan, M. S., A. B. Lentsch, M. Miyasaka, and P. A. Ward. 1998. Cytokine and adhesion molecule requirements for neutrophil recruitment during glycogen-induced peritonitis. Inflamm. Res. 47:251-255.
27. Nassar, G. M., A. Montero, M. Fukunaga, and K. F. Badr. 1997. Contrasting effects of proinflammatory and T-helper lymphocyte subset-2 cytokines on the 5-lipoxygenase pathway in monocytes. Kidney Int. 51:1520-1528.
28. PHLS Epidemiological Research Laboratory and 21 Area Health Authorities. 1982. Efficacy of pertussis vaccination in England. Br. Med. J. 285:357-359.
29. Redhead, K., J. Watkins, A. Barnard, and K. H. Mills. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:3190-3198.
30. Ryan, M., G. Murphy, L. Gothefors, L. Nilsson, J. Storsaeter, and K. H. Mills. 1997. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175:1246-1250.
31. Ryan, M., G. Murphy, E. Ryan, L. Nilsson, F. Shackley, L. Gothefors, K. Oymar, E. Miller, J. Storsaeter, and K. H. Mills. 1998. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10.
32. Saleem, S., Z. Dai, S. N. Coelho, B. T. Konieczny, K. J. Assmann, F. K. Baddoura, and F. G. Lakkis. 1998. IL-4 is an endogenous inhibitor of neutrophil influx and subsequent pathology in acute antibody-mediated inflammation. J. Immunol. 160:979-984.
33. Saukkonen, K., C. Cabellos, M. Burroughs, S. Prasad, and E. Tuomanen. 1991. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1143-1149.
34. Schreiber, S., T. Heinig, U. Panzer, R. Reinaking, A. Bouchard, P. D. Stahl, and A. Raedler. 1995. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108: 21-33.
35. Schuler, T., Z. Qin, S. Ibe, N. Noben-Trauth, and T. Blankenstein. 1999. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J. Exp. Med. 89:803-810.
36. Simondon, F., M.-P. Preziosi, A. Yam, C. T. Kane, L. Chabirand, I. Iteman, G. Sanden, S. Mboup, A. Hoffenbach, K. Knudsen, N. Guiso, S. Wassilak, and M. Cadoz. 1997. A randomized double blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 15:1606-1612.
37. Standiford, T. J., R. M. Strieter, S. W. Chensue, J. Westwick, K. Kasahara, and S. L. Kunkel. 1990. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Immunol. 145:1435-1439.
38. Steed, L. L., M. Setareh, and R. L. Friedman. 1991. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes. J. Leukoc. Biol. 50:321-330.
39. Tilg, H., C. A., Dinarello, and J. W. Mier. 1997. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today 18:428-432.
40. Vannier, E., L. C. Miller, and C. A. Dinarello. 1992. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 89:4076-4080.
41. Wertheim, W. A., S. L. Kunkel, T. J. Standiford, M. D. Burdick, F. S. Becker, C. A. Wilke, A. R. Gilbert, and R. M. Strieter. 1993. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 151:2166-2175.
42. Wong, H. L., G. L. Costa, M. T. Lotze, and S. M. Wahl. 1993. Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J. Exp. Med. 177:775-781.
43. Xu, W. B., E. B. Haddad, H. Tsukagoshi, I. Adcock, P. J. Barnes, and K. F. Chung. 1995. Induction of macrophage inflammatory protein 2 gene expression by interleukin 1 beta in rat lung. Thorax 50:1136-1140.